NEW YORK (GenomeWeb News) – The Burzynski Research Institute has struck a research agreement with the University of Alabama at Birmingham, under which the school will provide bioinformatics and data management support for the company's glioma treatment studies.

BRI, a Houston-based company focused on using genomics and epigenomics for cancer studies, said that UAB's Biostatistics and Bioinformatics Shared Facility (BBSF) will support its Phase I and Phase II protocol studies of Antineoplaston therapy, a treatment for gliomas.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Robert Redfield is floated as the next director of the US Centers for Disease Control and Prevention, the Washington Post reports.

The New York Times writes that the National Institutes of Health's All of Us Research Program is "ambitious" and that some are concerned it might be overly so.

Representative Lamar Smith's criticism of the National Science Foundation has "changed the nature of the conversation," according to ScienceInsider.

In PLOS this week: non-coding RNA function in yeast, transcriptomic profiles of malaria parasites, and more.